Fibroblast Growth Factor-2 (FGF2) and Syndecan-1 (SDC1) Are Potential Biomarkers for Putative Circulating CD15+/CD30+ Cells in Poor Outcome Hodgkin Lymphoma Patients
Journal of Hematology and Oncology - United Kingdom
doi 10.1186/1756-8722-6-62
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2013
Authors
Publisher
Springer Science and Business Media LLC